Trace Neuroscience

Eikonoklastes Therapeutics

This clinical stage biopharmaceutical company develops gene therapies for patients suffering from amyotrophic lateral sclerosis and other neurodegenerative diseases.

QurAlis

This company develops precision medicines for patients with amyotrophic lateral sclerosis, frontotemporal dementia, and other neurodegenerative diseases.

Crucible Therapeutics

This biotechnology company develops RNA-based therapies for patients with neurodegenerative conditions such as amyotrophic lateral sclerosis and frontotemporal dementia.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

2N Pharma

This biopharmaceutical company develops small molecule drugs to treat neurodegenerative diseases, including amyotrophic lateral sclerosis and Parkinson’s, for patients with unmet medical needs.

BE Therapeutics

This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.

Neuroplast

This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.

Tetraneuron

This company develops gene therapies to treat Alzheimer's and other neurodegenerative diseases for healthcare providers and patients.